Tag: FDA
-
Revive Therapeutics’ (RVV.C) product pipeline is flowing freakishly fast
Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19)
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
![Big Tobacco player Altria (MO.NYSE) lobbying hard for hemp, but is it the magic bullet Congress is counting on?]()
Big Tobacco player Altria (MO.NYSE) lobbying hard for hemp, but is it the magic bullet Congress is counting on?
Tobacco giant, Altria Group (MO.NYSE), is lobbying in the United States for “matters pertaining to hemp and crop insurance,” among other things, seemingly aiming to pivot away from vaping amidst a national health emergency. A lobbying report filed by The Russell Group listed its income for the quarter on behalf of Altria as $60,000, a…
